24 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
and that is still valid; or
at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending
F-3
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Shelf registration (foreign)
8:14am
in the same matter between the same parties and that is still valid; or
at the time the action was brought in the foreign court, a lawsuit in the same matter
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
Israeli plaintiff filed a request in the Israeli court of Tel Aviv to approve an Israeli class action lawsuit against the Company. The claim alleges
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
to approve his lawsuit as an Israeli class action lawsuit against the Company. The claim alleges that the Company did not make various documents filed
6-K
EX-1.1
ap11 hop5f6kuv5fp
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
o4wck0ne9 oi
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
75jpk4ixl dw
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
d0si7kq zk0yz
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
uf545a4n8n68146q6m19
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
w86wiuubhgn xgdy
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
2dzgqfq96p890mkm9441
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
46x277kiau6p6 wp
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
57689rd
26 Feb 20
Prospectus supplement for primary offering
8:23am
424B5
yawl3 wy2et7re
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
xt64qu9318
10 Jul 19
Prospectus supplement
8:18am
F-3
ck2tpg7xy7
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
j523eauc5mje1
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.1
yspow80uu86zyef uez1
19 Feb 19
Asset Purchase Agreement
4:57pm